These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 6395125

  • 1. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M.
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Sep; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases].
    Nafe R, Holgado de Colombo S, Choritz H, Georgii A.
    Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A, Kónya T, Wéber E.
    Orv Hetil; 1992 Jun 28; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [Abstract] [Full Text] [Related]

  • 11. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H.
    J Pathol; 2005 Apr 28; 205(5):548-57. PubMed ID: 15726648
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
    Michiels JJ.
    Neth J Med; 1997 Aug 28; 51(2):57-64. PubMed ID: 9286142
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
    Thiele J, Holgado S, Choritz H, Georgii A.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982 Aug 28; 41(1-2):67-81. PubMed ID: 6134385
    [Abstract] [Full Text] [Related]

  • 16. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
    Burkhardt R, Kronseder A.
    Fortschr Med; 1977 May 19; 95(19):1261-6. PubMed ID: 863367
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
    Nafe R, Georgii A, Kaloutsi V, Fritsch RS, Choritz H.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 May 19; 61(2):111-6. PubMed ID: 1683718
    [Abstract] [Full Text] [Related]

  • 19. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
    Rudzki Z, Papla B, Stachura J.
    Pol J Pathol; 2004 May 19; 55(1):13-23. PubMed ID: 15195702
    [Abstract] [Full Text] [Related]

  • 20. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
    Kreipe HH.
    Veroff Pathol; 1993 May 19; 141():1-158. PubMed ID: 8372486
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.